Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Glioma × Azacitidine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 189 Myelodysplastic Syndromes 78 Leukemia 40 Leukemia, Myelomonocytic, Chronic 32 Recurrence 15 Myeloproliferative Disorders 12 Neoplasm, Residual 10 Lymphoma, T-Cell, Peripheral 10 Leukemia, Biphenotypic, Acute 10 Lymphoma 8 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 7 Myelodysplastic-Myeloproliferative Diseases 7 Anemia, Refractory, with Excess of Blasts 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Lymphoma, Non-Hodgkin 6 Primary Myelofibrosis 5 Lymphoma, Large B-Cell, Diffuse 5 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Hodgkin Disease 5 Hematologic Neoplasms 5 Congenital Abnormalities 5 Multiple Myeloma 4 Lymphoma, T-Cell 4 Lymphoma, Follicular 4 Breast Neoplasms 4 Polycythemia Vera 3 Pancreatic Neoplasms 3 Neoplasm Metastasis 3 Lymphoma, Extranodal NK-T-Cell 3

Interventions

Temozolomide 99 Magnetic Resonance Spectroscopy 46 Bevacizumab 46 Radiotherapy 41 Irinotecan 23 Blood Specimen Collection 15 Aminolevulinic Acid 15 Surgical Procedures, Operative 13 Radiation 13 Carboplatin 13 Nivolumab 12 fluorodopa F 18 10 Radiotherapy, Intensity-Modulated 10 Radiosurgery 10 Carmustine 10 pembrolizumab 9 Topotecan 9 Surveys and Questionnaires 8 Specimen Handling 8 Magnetic Resonance Imaging 8 Erlotinib Hydrochloride 8 Biopsy 8 poly ICLC 7 Standard of Care 7 Filgrastim 7 Everolimus 7 Etoposide 7 Drug Therapy 7 Cyclophosphamide 7 ribociclib 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03666559 2024-02-29

AGIR

Assistance Publique - Hôpitaux de Paris

Phase 2 Unknown

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡